Substance / Medication

Thiamylal sodium

Overview

Active Ingredient
thiamylal
RxNorm CUI
10464

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Thiamylal sodium increased inflammation and the proliferation of vascular smooth muscle cells.
Miyazaki Ryohei, Hoka Sumio · Korean J Anesthesiol · 2016
PMID: 27274372OtherFull text (PMC)
Euthanasia efficacy and plasma biochemical implications of intraperitoneal thiamylal sodium in three rat strains.
Sasaki Takeru, Watanabe Masaki, Omori Tomoki et al. · J Vet Med Sci · 2026
PMID: 41183963Preclinical
Assessment of thiamylal sodium as a euthanasia drug in mice.
Watanabe Masaki, Hashimoto Kazuki, Ishii Yuki et al. · J Vet Med Sci · 2024
PMID: 38556347PreclinicalFull text (PMC)
Citosol (thiamylal sodium) triggers apoptosis and affects gene expressions of murine leukemia RAW 264.7 cells.
Wu R S-C, Yu C-S, Liu K-C et al. · Hum Exp Toxicol · 2012
PMID: 22895347Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Thiamylal sodium (substance)
SNOMED CT
40342009
UMLS CUI
C0700559
RxNorm CUI
10464

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

1
Conditions
1
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.